* Ocean Biomedical Inc OCEA.OQ OCEA.O is expected
to report
resultson March 20 (estimated) for the period ending September
30 2023
*
* LSEG's mean analyst estimate for Ocean Biomedical Inc is
for a
loss of 15 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ocean
Biomedical
Inc is $17.45, above its last closing price of $4.12.
This summary was machine generated March 18 at 20:03 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)